Integer Holdings Corp.
06/26/2026 | Press release | Distributed by Public on 06/26/2026 14:20
Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 24, 2026, the Compensation and Organization Committee (the "Committee") of the Board of Directors (the "Board") of Integer Holdings Corporation (the "Company") approved certain changes to the compensation for Jim Stephens, the Company's current President, Cardiac Rhythm Management & Neuromodulation, in connection with his transition to the role of Executive Vice President, Special Projects, effective June 29, 2026. Pursuant to a letter agreement entered into by the Company and Mr. Stephens, dated June 26, 2026, this new role will end on March 31, 2027 (the "Termination Date") (unless otherwise terminated by Mr. Stephens or the Company). Further, if (i) a Change of Control (as such term is defined in the Amended and Restated Change of Control Agreement, dated as of May 22, 2026, between Mr. Stephens and the Company (the "CIC Agreement")) occurs on or prior to the Termination Date and (ii) Mr. Stephens remain employed through the Termination Date, his separation on the Termination Date will be considered a termination without Cause (as such term is defined in the CIC Agreement) for purposes of the CIC Agreement. Mr. Stephens will not be eligible for a short-term or long-term incentive award in 2027. All other terms and conditions of his employment remain the same.
Integer Holdings Corp. published this content on June 26, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 26, 2026 at 20:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]